While, the percentages of tumor cases showing NGAL transcripts below the 25th percentile of “normal” values were almost 100% of all hematological malignancies and 94.6% of head and neck cancer, 71.4% of esophagus cancer and 59.4% of cervical carcinoma. The gene discussed is LCN2; the disease is hematologic disorder.